Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
244 | 3 | IMMUNOLOGY//PHAGE DISPLAY//BIOSIMILAR | 47231 |
1376 | 2 | BIOSIMILAR//FCRN//ANTIBODY DRUG CONJUGATE | 8436 |
12413 | 1 | ANTIBODY DRUG CONJUGATE//TRASTUZUMAB EMTANSINE//T DM1 | 938 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ANTIBODY DRUG CONJUGATE | authKW | 3436992 | 21% | 51% | 200 |
2 | TRASTUZUMAB EMTANSINE | authKW | 358357 | 3% | 44% | 24 |
3 | T DM1 | authKW | 354943 | 3% | 39% | 27 |
4 | MAYTANSINOID | authKW | 345581 | 1% | 86% | 12 |
5 | ANTIBODY DRUG CONJUGATE ADC | authKW | 329257 | 1% | 70% | 14 |
6 | DRUG TO ANTIBODY RATIO | authKW | 305439 | 1% | 91% | 10 |
7 | AURISTATIN | authKW | 225848 | 1% | 61% | 11 |
8 | ANTIBODY DRUG CONJUGATES ADCS | authKW | 209983 | 1% | 63% | 10 |
9 | SITE SPECIFIC CONJUGATION | authKW | 209766 | 2% | 39% | 16 |
10 | DRUG ANTIBODY RATIO | authKW | 172791 | 1% | 86% | 6 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Biochemical Research Methods | 2846 | 19% | 0% | 177 |
2 | Oncology | 2044 | 25% | 0% | 239 |
3 | Chemistry, Multidisciplinary | 1096 | 24% | 0% | 225 |
4 | Chemistry, Organic | 1043 | 16% | 0% | 152 |
5 | Pharmacology & Pharmacy | 1031 | 21% | 0% | 198 |
6 | Chemistry, Medicinal | 492 | 7% | 0% | 70 |
7 | Medicine, Research & Experimental | 402 | 9% | 0% | 83 |
8 | Biochemistry & Molecular Biology | 349 | 20% | 0% | 185 |
9 | Chemistry, Analytical | 225 | 8% | 0% | 76 |
10 | Biotechnology & Applied Microbiology | 72 | 5% | 0% | 49 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOCONJUGATES DISCOVERY DEV | 134394 | 0% | 100% | 4 |
2 | PRECLIN TRANSLAT PHARMACOKINET PHARMACOD | 119992 | 1% | 71% | 5 |
3 | FUNCT CHEMOSYST UMR 7199 | 107514 | 0% | 80% | 4 |
4 | BIOORGAN MASS SPE OMETRY LSMBO | 89585 | 1% | 33% | 8 |
5 | PRECLIN TRANSLAT PHARMACOKINET PHARMACODYNAM | 75595 | 0% | 75% | 3 |
6 | BIOANALYT SCI LCMS | 67197 | 0% | 100% | 2 |
7 | BIOL P IMMUNOL | 67197 | 0% | 100% | 2 |
8 | BIOL DISCOVERY CALIF | 50389 | 1% | 25% | 6 |
9 | PRECLIN THER EUT | 39991 | 1% | 24% | 5 |
10 | PROT ANALYT CHEM | 38996 | 1% | 10% | 12 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOCONJUGATE CHEMISTRY | 70100 | 11% | 2% | 104 |
2 | MABS | 38026 | 3% | 4% | 30 |
3 | MOLECULAR CANCER THERAPEUTICS | 12125 | 4% | 1% | 39 |
4 | BIOANALYSIS | 8270 | 2% | 1% | 19 |
5 | AAPS JOURNAL | 7816 | 2% | 1% | 17 |
6 | MOLECULAR PHARMACEUTICS | 2865 | 2% | 1% | 17 |
7 | CLINICAL CANCER RESEARCH | 2494 | 4% | 0% | 34 |
8 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 1374 | 1% | 1% | 6 |
9 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 1363 | 1% | 1% | 5 |
10 | EXPERT OPINION ON BIOLOGICAL THERAPY | 1227 | 1% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |